news_6

Everest Medicines and Gilead Sciences Jointly Announce Phase 2b Study of Sacituzumab Govitecan Conducted in China of Patients With Metastatic Triple-Negative Breast Cancer Meets Primary Overall Response Rate Endpoint

generic_link-62

Workato Raises $200 Million Series E at a $5.7 Billion Valuation to Accelerate Record Growth and Capitalize on Surging Demand for Enterprise Automation

Funding will be used to further capitalize on rapidly growing automation market; accelerating global expansion and extending product leadership, as...